ClinicalTrials.govpublic full text
Pomalidomide for the Treatment of Bleeding in HHT
telangiectasia, hereditary hemorrhagic, epistaxis, pomalidomide, blood transfusion, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 919116
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.